The World Health Organization International Collaborative Study for Islet Cell Antibodies

ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES

Bottazzo, G., Florin-Christensen, A., & Doniach, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90140-8 · Cited by 1,469

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420

A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM

Grubin, C. E., Daniels, T., Toivola, B., Landin-Olsson, M., Hagopian, W. A., Li, L., Karlsen, A. E., Boel, E., Michelsen, B., & Lernmark, �. (1994) · Diabetologia · doi:10.1007/bf00408469 · Cited by 415

Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.

Bækkeskov, S., Landin, M., Kristensen, J. K., Srikanta, S., Bruining, G. J., Mandrup-Poulsen, T. R., de Beaufort, C. E., Soeldner, J. S., Eisenbarth, G. S., & Lindgren, F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112903 · Cited by 315

Islet-Cell Antibodies and Beta-Cell Function in Monozygotic Triplets and Twins Initially Discordant for Type I Diabetes Mellitus

Srikanta, S., Ganda, O. P., Eisenbarth, G. S., & Soeldner, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302103080607 · Cited by 224

ISLET-CELL ANTIBODIES IN JUVENILE DIABETES MELLITUS OF RECENT ONSET

Lendrum, R., Walker, G., & Gamble, D. R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91683-9 · Cited by 222

Disease Sensitivity and Specificity of 52 Assays for Glutamic Acid Decarboxylase Antibodies: The Second International GADAB Workshop

Schmidli, R. S., Colman, P. G., & Bonifacio, E. E. (1995) · Diabetes · doi:10.2337/diab.44.6.636 · Cited by 131

Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies

Bonifacio, E. E., Lernmark, Å., & Dawkins, R. L. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90274-8 · Cited by 107

Department of Biochemistry and Molecular Biology

Mitchell, A. (2006) · Cited by 104

Can Islet Cell Antibodies Predict IDDM in the General Population?

Bingley, P. J., Bonifacio, E. E., Shattock, M., Gillmor, H. A., Sawtell, P., Dunger, D. B., Scott, R. D. M., Bottazzo, G. F., & Gale, E. A. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.45 · Cited by 88

Type 1 diabetes mellitus

Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.16 · Cited by 1,475

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus

Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. A. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,132

Autoimmune Diseases

Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,069

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus

Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9998 · Cited by 718

Diabetes Antibody Standardization Program: first assay proficiency evaluation

Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351

Autoimmune type 1 diabetes: resolved and unresolved issues

Notkins, A. L., & Lernmark, Å. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14257 · Cited by 322

Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia

Bonifacio, E., Yu, L., Williams, A. K., Eisenbarth, G. S., Bingley, P. J., Marcovina, S. M., Adler, K., Ziegler, A. G., Mueller, P. W., Schatz, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0293 · Cited by 291

Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2

Törn, C., Mueller, P. W., Schlosser, M., Bonifacio, E., Bingley, P. J., & Laboratories, P. (2008) · Diabetologia · doi:10.1007/s00125-008-0967-2 · Cited by 284

Ketosis-Prone Diabetes: Dissection of a Heterogeneous Syndrome Using an Immunogenetic and β-Cell Functional Classification, Prospective Analysis, and Clinical Outcomes

Maldonado, M., Hampe, C. S., Gaur, L. K., D’Amico, S., Iyer, D., Hammerle, L. P., Bolgiano, D. C., Rodriguez, L., Rajan, A. S., Lernmark, Å., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030180 · Cited by 233

Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes

Graham, J., Hagopian, W. A., Kockum, I., Li, L. S., Sanjeevi, C. B., Lowe, R. M., Schaefer, J. B., Zarghami, M., Day, H. L., Landin-Olsson, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1346 · Cited by 230

Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies

Laboratories, P., Schlosser, M., Mueller, P. W., Törn, C., Bonifacio, E. E., & Bingley, P. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1915-5 · Cited by 180

Analysis of GAD65 Autoantibodies in Stiff-Person Syndrome Patients

Raju, R. P., Foote, J., Banga, J. P., Hall, T. R., Padoa, C. J., Dalakas, M. C., Örtqvist, E., & Hampe, C. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7755 · Cited by 156

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 164

Diabetes Antibody Standardization Program: First Proficiency Evaluation of Assays for Autoantibodies to Zinc Transporter 8

Lampasona, V., Schlosser, M., Mueller, P. W., Williams, A. J. K., Wenzlau, J. M., Hutton, J. C., Achenbach, P., & Laboratories, P. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.170662 · Cited by 112

Islet Autoantibody Standardization Program 2018 workshop: interlaboratory comparison of glutamic acid decarboxylase autoantibody assay performance

Lampasona, V., Pittman, D. L., Williams, A. J., Achenbach, P., Schlosser, M., Akolkar, B., Winter, W. E., Laboratories, P., Watson, K., Weets, I., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.304196 · Cited by 103

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)

Bottazzo, G. F., Bosi, E., Cull, C. A., Bonifacio, E. E., Locatelli, M., Zimmet, P., Mackay, I. R., & Holman, R. R. (2005) · Diabetologia · doi:10.1007/s00125-005-1691-9 · Cited by 101

A high prevalence of organ-specific autoimmunity in patients with bipolar disorder

Padmos, R. C., Bekris, L. M., Knijff, E. M., Tiemeier, H. W., Kupka, R., Cohen, D., Nolen, W. A., Lernmark, Å., & Drexhage, H. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.003 · Cited by 99

Development of Type 1 Diabetes in Wild Bank Voles Associated With Islet Autoantibodies and the NovelLjungan Virus

Niklasson, B., Heller, K. E., Schønecker, B., Bildsøe, M., Daniels, T. L., Hampe, C. S., Widlund, P. O., Simonson, W. T., Schaefer, J. B., Rutledge, E. A., et al. (2003) · Journal of Diabetes Research · doi:10.1080/15438600303733 · Cited by 92

ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset

Vaziri‐Sani, F., Oak, S. A., Radtke, J. R., Lernmark, Å., Lynch, K. F., Agardh, C. D., Cilio, C., Lethagen, Å., Örtqvist, E., Landin‐Olsson, M., et al. (2010) · Autoimmunity · doi:10.3109/08916930903555927 · Cited by 87

The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus

van Deutekom, A. W., Heine, R. J., & Şimşek, S. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02316.x · Cited by 87

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions

Manto, M. U., Honnorat, J., Hampe, C. S., Guerra-Narbona, R., López, J. C., Delgado-Garcia, J. M., Saitow, F., Suzuki, H., Yanagawa, Y., Mizusawa, H., et al. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00078 · Cited by 85

Zinc Transporter 8 Autoantibodies and Their Association WithSLC30A8andHLA-DQGenes Differ Between Immigrant and Swedish Patients With Newly Diagnosed Type 1 Diabetes in the Better Diabetes Diagnosis Study

Delli, A. J., Vaziri‐Sani, F., Lindblad, B., Larsson, H. E., Carlsson, A., Forsander, G., Ivarsson, S. A., Ludvigsson, J., Kockum, I. S., Marcus, C., et al. (2012) · Diabetes · doi:10.2337/db11-1659 · Cited by 81

Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes

Zhao, L. P., Alshiekh, S., Zhao, M. A., Carlsson, A., Larsson, H. E., Forsander, G., Ivarsson, S. A., Ludvigsson, J., Kockum, I. S., Marcus, C., et al. (2016) · Diabetes · doi:10.2337/db15-1115 · Cited by 76

Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes

Andersson, C. K., Vaziri‐Sani, F., Delli, A. J., Lindblad, B., Carlsson, A., Forsander, G., Ludvigsson, J., Marcus, C., Samuelsson, U., Ivarsson, S., et al. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00916.x · Cited by 74

A sensitive non-isotopic assay for GAD65 autoantibodies

Brooking, H., Ananieva-Jordanova, R., Arnold, C., Amoroso, M., Powell, M. J., Betterle, C., Zanchetta, R., Furmaniak, J., & Smith, B. R. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00088-3 · Cited by 73

Elimination of Dietary Gluten Does Not Reduce Titers of Type 1 Diabetes-Associated Autoantibodies in High-Risk Subjects

Hummel, M., Bonifacio, E. E., Naserke, H. E., & Ziegler, A. G. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1111 · Cited by 69

Harmonization of immunoassays for biomarkers in diabetes mellitus

Hörber, S., Achenbach, P., Schleicher, E. D., & Peter, A. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.015 · Cited by 77

Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes

Schlosser, M., Banga, J. P., Madec, A., Binder, K. A., Strebelow, M., Rjasanowski, I. M., Waßmuth, R., Gilliam, L. K., Luo, D., & Hampe, C. S. (2005) · Diabetologia · doi:10.1007/s00125-005-1719-1 · Cited by 69

Series Introduction: Autoimmune diseases: are markers ready for prediction?

Lernmark, Å. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200114234 · Cited by 64

Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden

for the Swedish Better Diabetes Diagnosis Study Group, Carlsson, A., Kockum, I. S., Lindblad, B., Engleson, L., Nilsson, A. C., Forsander, G., Karlsson, A., Kernell, A., Ludvigsson, J., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.122 · Cited by 61

Predicting type 1 diabetes

Achenbach, P., Bonifacio, E. E., & Ziegler, A. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0035-y · Cited by 60

Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes

Antonelli, A., Tuomilehto, J., Nannipieri, M., Fallahi, P., Nesti, C., Okamoto, H., Groop, L., & Ferrannini, E. (2002) · Diabetologia · doi:10.1007/s00125-002-0886-6 · Cited by 55

High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon α for chronic hepatitis C virus infection

Schreuder, T. C. M. A., Gelderblom, H. C., Weegink, C. J., Hamann, D., Reesink, H. W., DeVries, J. H., Hoekstra, J. B. L., & Jansen, P. L. M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01610.x · Cited by 52

Classificação do diabete melito

Maraschin, J. D. F., Murussi, N., Witter, V., & Silveiro, S. P. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010001200025 · Cited by 53

Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review

Felton, J. L., REDONDO, M. J., Oram, R. A., Speake, C., Long, S. A., Önengüt-Gümüşcü, S., Rich, S. S., Monaco, G. S. F., Harris-Kawano, A., Perez, D., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00478-y · Cited by 63

Thyroid and islet autoantibodies predict autoimmune thyroid disease already at Type 1 diabetes diagnosis

Jónsdóttir, B., Larsson, C., Carlsson, A., Forsander, G., Ivarsson, S. A., Lernmark, Å., Ludvigsson, J., Marcus, C., Samuelsson, U., Örtqvist, E., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2335 · Cited by 47

IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5

Shin, J.-H., Janer, M., McNeney, B., Blay, S., Deutsch, K., SANJEEVI, C. B., Kockum, I. S., Lernmark, Å., Graham, J., & Groups, O. B. O. T. S. C. D. A. T. D. I. I. S. S. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364413 · Cited by 46

Prenatal viral exposure followed by adult stress produces glucose intolerance in a mouse model

Niklasson, B., Samsioe, A., Blixt, M., Sandler, S., Sjöholm, Å., Lagerquist, E., Lernmark, Å., & Klitz, W. (2006) · Diabetologia · doi:10.1007/s00125-006-0339-8 · Cited by 44

Autoimmunity against INS-IGF2 Protein Expressed in Human Pancreatic Islets*

Kanatsuna, N., Taneera, J., Vaziri‐Sani, F., Wierup, N., Larsson, H. E., Delli, A. J., Skärstrand, H., Balhuizen, A., Bennet, H., Steiner, D. F., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478222 · Cited by 43

Immunology of β-Cell Destruction

Torre, D. L., & Lernmark, Å. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_24 · Cited by 43

Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents

for the Better Diabetes Diagnosis (BDD) study group, Jónsdóttir, B., Andersson, C. K., Carlsson, A., Delli, A. J., Forsander, G., Ludvigsson, J., Marcus, C., Samuelsson, U., Örtqvist, E., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2934-9 · Cited by 40

Chapter 3 GAD65 Autoimmunity—Clinical Studies

Uibo, R., & Lernmark, Å. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00803-1 · Cited by 42

Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease

Lind, A., Cortez, F. D. J., Ramelius, A., Bennet, R., Robinson, P. V., Seftel, D., Gebhart, D., Tandel, D., Maziarz, M., Agardh, D., et al. (2022) · Journal of Immunological Methods · doi:10.1016/j.jim.2022.113265 · Cited by 36

A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.

Rahmati, K., Lernmark, Å., Becker, C., Foltyn-Zadura, A., Larsson, K., Ivarsson, S.-A., & Törn, C. (2008) · PubMed · Cited by 32

Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65

Chen, S., Willis, J. A., Maclean, C., Ananieva-Jordanova, R., Amoroso, M., Brooking, H., Powell, M. J., Collins, A., Bennett, S., Mitchell, S. E., et al. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.006 · Cited by 33

The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies

Maziarz, M., Janer, M., Roach, J. C., Hagopian, W., Palmer, J. P., Deutsch, K., Sanjeevi, C. B., Kockum, I. S., Breslow, N. E., Lernmark, Å., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.12 · Cited by 32

Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A − β + Ketosis-Prone Diabetes (KPD): The first identified cohort amongst Asian Indians

Gupta, R. D., Ramachandran, R., Gangadhara, P., Shajith Anoop, S., Singh, S. H., Satyaraddi, A., Sathyakumar, S., Asha, H. S., & Thomas, N. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.06.008 · Cited by 28

Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA)

Radenkovic, M., Silver, C., Arvastsson, J., Lynch, K. F., Lernmark, Å., Harris, R. A., Agardh, C., & Cilio, C. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12834 · Cited by 29

Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories

Bingley, P. J., Williams, A. J. K., Colman, P. G., Gellert, S. A., Eisenbarth, G. S., Yu, L., Perdue, L., Pierce, J. J., Hilner, J. E., Nierras, C. R., et al. (2010) · Clinical Trials · doi:10.1177/1740774510373496 · Cited by 26

Evidence for immunological priming and increased frequency of CD4+ CD25+ cord blood T cells in children born to mothers with type 1 diabetes

Holm, B., Svensson, J., Åkesson, C., Arvastsson, J., Ljungberg, J., Lynch, K., Ivarsson, S., Lernmark, Å., Cilio, C., & (DiPiS), D. P. S. I. S. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03243.x · Cited by 25

The Better Diabetes Diagnosis (BDD) study – A review of a nationwide prospective cohort study in Sweden

Persson, M., Becker, C., Larsson, H. E., Lernmark, Å., Forsander, G., Ivarsson, S. A., Ludvigsson, J., Samuelsson, U., Marcus, C., & Carlsson, A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.057 · Cited by 26

Immunomodulation with human recombinant autoantigens

Lernmark, Å., & Agardh, C.-D. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.015 · Cited by 24

Possible heterogeneity of initial pancreatic islet beta‐cell autoimmunity heralding type 1 diabetes

Lernmark, Å., Akolkar, B., Hagopian, W., Krischer, J. P., McIndoe, R., Rewers, M., Toppari, J., Vehik, K., Ziegler, A., & The TEDDY Study Group (2023) · Journal of Internal Medicine · doi:10.1111/joim.13648 · Cited by 26

High frequency of autoantibodies in patients with long duration type 1 diabetes

Richardson, C. C., Dromey, J. A., McLaughlin, K. A., Morgan, D., Bodansky, H. J., Feltbower, R. G., Barnett, A. H., Gill, G. V., Bain, S. C., & Christie, M. R. (2013) · Diabetologia · doi:10.1007/s00125-013-3017-7 · Cited by 23

Autoimmunity plays a role in the onset of diabetes after 40 years of age

Rolandsson, O., Hampe, C. S., Sharp, S. J., Ardanáz, E., Boeing, H., Fagherazzi, G., Mancini, F. R., Nilsson, P. M., Overvad, K., Chirlaque, M., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05016-3 · Cited by 23

GAD65 autoantibody epitopes in adult patients with latent autoimmune diabetes following GAD65 vaccination

Bekris, L. M., Jensen, R. A., Lagerquist, E., Hall, T. R., Agardh, C. –., Cilio, C., Lethagen, Å., Lernmark, Å., Robertson, J. A., & Hampe, C. S. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02091.x · Cited by 20

Time-resolved Fluorometric Assay for Detection of Autoantibodies to Glutamic Acid Decarboxylase (GAD65)

Ankelo, M., Westerlund‐Karlsson, A., Ilonen, J., Knip, M., Savola, K., Kankaanpää, P., Meriö, L., Siitari, H., & Hinkkanen, A. (2003) · Clinical Chemistry · doi:10.1373/49.6.908 · Cited by 19

Changes in GAD65Ab-Specific Antiidiotypic Antibody Levels Correlate with Changes in C-Peptide Levels and Progression to Islet Cell Autoimmunity

Örtqvist, E., Brooks‐Worrell, B., Lynch, K. F., Radtke, J. R., Bekris, L. M., Kockum, I. S., Agardh, C. –., Cilio, C., Lethagen, Å., Persson, B., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0785 · Cited by 18

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies

Maziarz, M., Hagopian, W., Palmer, J. P., Sanjeevi, C. B., Kockum, I. S., Breslow, N. E., Lernmark, Å., Graham, J., MacNeney, B., Arnqvist, H. J., et al. (2015) · Genes and Immunity · doi:10.1038/gene.2015.43 · Cited by 19

The PEVKEK Region of the Pyridoxal Phosphate Binding Domain of GAD65 Expresses a Dominant B Cell Epitope for Type 1 Diabetes Sera

TONG, J. C., Myers, M. A., MACKAY, I. R., Zimmet, P., & Rowley, M. J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02966.x · Cited by 16

Epitope analysis of insulin autoantibodies using recombinant Fab

Padoa, C. J., Crowther, N. J., Thomas, J. W., Hall, T. R., Bekris, L. M., Törn, C., Landin‐Olsson, M., Örtqvist, E., Palmer, J. P., Lernmark, Å., et al. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02802.x · Cited by 17

Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes

Lernmark, Å. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15381 · Cited by 16

Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays

Lind, A., Freyhult, E., Cortez, F. D. J., Ramelius, A., Bennet, R., Robinson, P. V., Seftel, D., Gebhart, D., Tandel, D., Maziarz, M., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105144 · Cited by 18

A Simple and Fast Non-Radioactive Bridging Immunoassay for Insulin Autoantibodies

Kikkas, I., Mallone, R., Tubiana‐Rufi, N., Chevenne, D., Carel, J., Créminon, C., Volland, H., Boîtard, C., & Morel, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069021 · Cited by 15

Predicting Type 1 Diabetes Using Autoantibodies: The Latest Results from the Diabetes Autoantibody Standardization Program

Mueller, P. W., Bingley, P. J., Bonifacio, E. E., STEINBERG, K. K., & Sampson, E. J. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502760098537 · Cited by 15

Auto-Antikörper-Diagnostik in der Diabetologie – Aktueller Stand der Analytik und klinische Anwendung in Deutschland

Thaler, M., Roos, M., Petersmann, A., Seißler, J., Peter, A., Landgraf, R., Müller, U., Müller‐Wieland, D., Nauck, M. A., Heinemann, L., et al. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1744-2856 · Cited by 14

Validation of Autoantibody Assays in Type 1 Diabetes: Workshop Programme

Bingley, P. J., & Williams, A. J. K. (2004) · Autoimmunity · doi:10.1080/08916930410001710677 · Cited by 13

Number of islet autoantibodies present in newly diagnosed type 1 diabetes children born to non-diabetic mothers is affected by islet autoantibodies present at birth

Elfving, M., Lindberg, B. A., Lynch, K. F., Månsson, M., Sundkvist, G., Lernmark, Å., & Ivarsson, S. A. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00349.x · Cited by 13

Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes

Lernmark, Å. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215381 · Cited by 13

Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling

O'Connor, K. H., Banga, J. P., Darmanin, C., El-Kabbani, O. A. L., Mackay, I. R., & Rowley, M. J. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.02.001 · Cited by 12

Standardization of antibody preparations for use in immunogenicity studies: a case study using the World Health Organization International Collaborative Study for Islet Cell Antibodies.

Mire‐Sluis, A. R., Das, R. G., & Lernmark, Å. (2003) · PubMed · Cited by 11

Interaction Between GAD65 Antibodies and Dietary Fish Intake or Plasma Phospholipid n-3 Polyunsaturated Fatty Acids on Incident Adult-Onset Diabetes: The EPIC-InterAct Study

Löfvenborg, J. E., Carlsson, S., Andersson, T., Hampe, C. S., Koulman, A., López, M. D. C., Jakszyn, P. G., Katzke, V. A., Kuhn, T. E., Kyrø, C., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1463 · Cited by 10

An Increased Diagnostic Sensitivity of Truncated GAD65 Autoantibodies in Type 1 Diabetes May Be Related to HLA-DQ8

Wester, A., Skärstrand, H., Lind, A., Ramelius, A., Carlsson, A., Cedervall, E., Jönsson, B., Ivarsson, S. A., Larsson, H. E., Larsson, K., et al. (2016) · Diabetes · doi:10.2337/db16-0891 · Cited by 10

Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin?GAD65 fusion protein

Luo, D., Rogers, C. N., Steed, J., Gilliam, L. K., Hampe, C. S., & Lernmark, Å. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.03.009 · Cited by 11

High-titer GAD65 autoantibodies detected in adult diabetes patients using a high efficiency expression vector and cold GAD65 displacement

Hansson, I., Lynch, K. F., Hallmans, G., Lernmark, Å., & Rolandsson, O. (2010) · Autoimmunity · doi:10.3109/08916934.2010.482117 · Cited by 10

Doubly Reactive INS ‐ IGF 2 Autoantibodies in Children with Newly Diagnosed Autoimmune (type 1) Diabetes

Kanatsuna, N., Delli, A. J., Andersson, C. K., Nilsson, A. ‐., Vaziri‐Sani, F., Larsson, K., Carlsson, A., Cedervall, E., Jönsson, B., Neiderud, J., et al. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12325 · Cited by 10

Type 1 Diabetes as a Model for Prediction and Diagnosis

Lernmark, Å. (2004) · Autoimmunity · doi:10.1080/08916930410001726012 · Cited by 10

Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes

Larsson, H. E., Jönsson, I., Lernmark, Å., Ivarsson, S. A., Radtke, J. R., Hampe, C. S., (DiPiS), T. D. P. I. S., & Type 1 Diabetes Trial Network (2013) · PLoS ONE · doi:10.1371/journal.pone.0065173 · Cited by 8

Antigen presentation of detergent-free glutamate decarboxylase (GAD65) is affected by human serum albumin as carrier protein

Steed, J., Gilliam, L. K., Harris, R. A., Lernmark, Å., & Hampe, C. S. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.02.006 · Cited by 8

Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study

Lampousi, A., Carlsson, S., Löfvenborg, J. E., Cabrera-Castro, N., Chirlaque, M., Fagherazzi, G., Franks, P. W., Hampe, C. S., Jakszyn, P. G., Koulman, A., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05948-x · Cited by 8

Epitope-Restricted 65-Kilodalton Glutamic Acid Decarboxylase Autoantibodies among New-Onset Sardinian Type 2 Diabetes Patients Define Phenotypes of Autoimmune Diabetes

Maioli, M., Alejandro, E. U., Tonolo, G., Gilliam, L. K., Bekris, L. M., Hampe, C. S., Obinu, D. A., Manconi, A., Puddu, L., Lynch, K. F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0864 · Cited by 8

Islet Cell Autoantibodies in Cord Blood from Children with Blood Group Incompatibility or Hyperbilirubinemia

Elfving, Å., Lindberg, B. A., Landin‐Olsson, M., Hampe, C. S., Lernmark, Å., & Ivarsson, S. A. (2003) · Autoimmunity · doi:10.1080/0891693031000073109 · Cited by 8

Precision Diagnostics: Using Islet Autoantibodies to Characterize Heterogeneity in Type 1 DiabetesPreprint

Felton, J. L., REDONDO, M. J., Oram, R. A., Speake, C., Long, S. A., Önengüt-Gümüşcü, S., Rich, S. S., Monaco, G. S. F., Harris-Kawano, A., Perez, D., et al. (2023) · medRxiv · doi:10.1101/2023.04.18.23288756 · Cited by 8

Diabetes mellitus

Sacks, D. B. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00046-9 · Cited by 7

Autoimmune (Type 1) Diabetes

Lindbladh, I., Svärd, A. A., & Lernmark, Å. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00041-5 · Cited by 8

Geographic location determines beta‐cell autoimmunity among adult Ghanaians: Findings from the RODAM study

Hampe, C. S., Sahabandu, D., Kaiser, V., Telieps, T., Smeeth, L. L., Agyemang, C. O., Spranger, J., Schulze, M. B., Mockenhaupt, F. P., Danquah, I., et al. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.306 · Cited by 7

Conformation-dependent GAD65 autoantibodies in diabetes

Luo, D., Gilliam, L. K., Greenbaum, C. J., Bekris, L. M., Hampe, C. S., Daniels, T. L., Richter, W., Marcovina, S. M., Rolandsson, O., Landin‐Olsson, M., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1495-3 · Cited by 7

HEPATIC DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS: COINCIDENCE OR CONVERGENCE

MACKAY, I. (2004) · Elsevier eBooks · doi:10.1016/b9-78-012433-9/01950-0387 · Cited by 6

A comparison of current methods to measure antibodies in type 1 diabetes

Infantino, M., Manfredi, M., Garrafa, E., Pancani, S., Lechiara, A., Mobilia, E. M., Grossi, V., Lari, B., Bizzaro, N., & Pesce, G. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-0238 · Cited by 6

Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies

Oak, S. A., Radtke, J. R., Landin‐Olsson, M., Törn, C., Lernmark, Å., & Hampe, C. S. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.09.004 · Cited by 6

Islet autoantibodies present in association with Ljungan virus infection in bank voles (Myodes glareolus) in northern Sweden

Warvsten, A., Björnfors, M., Arvidsson, M., Vaziri‐Sani, F., Jönsson, I., Olsson, G. E., Ahlm, C., Larsson, H. E., Lernmark, Å., & Nilsson, A.-L. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24597 · Cited by 6

A highly sensitive microsphere-based assay for early detection of Type I diabetes

Bale, S. S., Price, G. M., Casali, M., Saeidi, N., Bhushan, A., & Yarmush, M. L. (2014) · TECHNOLOGY · doi:10.1142/s2339547814500174 · Cited by 5

Autoimmune Diabetes Mellitus: The Importance of Autoantibodies for Disease Prediction and Diagnostic Support

Valdez, S. N., & Poskus, E. (2010) · Current Immunology Reviews · doi:10.2174/1573395511006040299 · Cited by 5

Islet Autoantibodies in Cord Blood from Patients who developed Type 1 Diabetes Mellitus at 15–30 Years of Age

Elfving, Å., Lindberg, B. A., Nyström, L., Sundkvist, G., Lernmark, Å., Ivarsson, S. A., & and the DISS Study Group (2003) · Autoimmunity · doi:10.1080/0891693031000141040 · Cited by 5

Temporal Variation of Ljungan Virus Antibody Levels in Relation to Islet Autoantibodies and Possible Correlation to Childhood Type 1 Diabetes

Nilsson, A.-L., Lagerquist, E., Lynch, K. F., Lernmark, Å., & Rolandsson, O. (2010) · The Open Pediatric Medicine Journal · doi:10.2174/1874309900903010061 · Cited by 5

Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de Chile

Vera, F., Jofré, P., Rodríguez, D., Lagos, R., Quiroga, T., Grassi, B. A., & Felipe Pollak, C. (2021) · Revista médica de Chile · doi:10.4067/s0034-98872021000300330 · Cited by 4

Autoimmunity and Immunotherapy of Type 1 Diabetes

Aribi, M. (2011) · InTech eBooks · doi:10.5772/20674 · Cited by 6

Clinical heterogeneity of adult Japanese diabetes depending on titers of glutamic acid decarboxylase autoantibodies

Aoyama, T., Ikeda, H., Hamamoto, Y., Honjo, S., Nomura, K., Wada, Y., Fujikawa, J., Hayashino, Y., Fukuhara, S., & Koshiyama, H. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00190.x · Cited by 4

Untitled work

(1999) · doi:10.1002/(sici)1520-7560(199901/02)15:1

Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories

Bingley, P. J., Williams, A. J. K., Colman, P. G., Gellert, S. A., Eisenbarth, G. S., Yu, L., Perdue, L., Pierce, J. J., Hilner, J. E., Nierras, C. R., et al. (2010) · Clinical Trials · doi:10.1177/1740774510373496 · Cited by 26

Towards a World Health Organisation (WHO) approved standard sample for islet cell antibodies, GAD65 and IA-2 autoantibodies

Available, N. A. N. (1999) · Diabetologia · doi:10.1007/s001250051167 · Cited by 15

The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies

Lernmark, Å., Molenaar, J. L., van Beers, W. A. M., Yamaguchi, Y., Nagataki, S., Ludvigsson, J., Maclaren, N. K., Arnaiz‐Villena, A., Barbosa, J., deBeaufort, C., et al. (1991) · Diabetologia · doi:10.1007/bf00403293 · Cited by 69

Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories

A, P. J. B., Williams, A. J. K., B, P. G. C., Gellert, S. A., Eisenbarth, G. S., Liping Yu, C., D, L. H. P., Pierce, J. J., E, J. E. H., Concepcion Nierras, F., et al. (2013)